Image

Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction

Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction

Recruiting
40-80 years
All
Phase N/A

Powered by AI

Overview

This study aims to investigate the effects of motor-cognitive interactive robot-assisted training on improving upper limb motor dysfunction after stroke. By observing different combinations of motor and cognitive components in the training, the study will clarify the relationship between the proportion of motor and cognitive elements and the recovery of upper limb motor function. The goal is to optimize the training protocol for upper limb rehabilitation robots and enhance their therapeutic outcomes.

Participants will be randomly assigned to one of three groups: motor-cognitive interactive robot-assisted training, motor-focused robot-assisted training, or conventional rehabilitation training. Training sessions will last 60 minutes, occur 5 times per week, and continue for 4 weeks. Researchers will measure changes in upper limb function and monitor for any adverse events during the training.

Eligibility

Inclusion Criteria:

  1. Diagnosis of stroke confirmed by CT or MRI.
  2. Age between 40 and 80 years, with no gender restrictions.
  3. First-ever stroke with unilateral limb paralysis.
  4. Onset of stroke between 2 weeks and 6 months prior, with an FMA-UE score of 8-44.
  5. Willingness to participate and provide written informed consent.

Exclusion Criteria:

  1. History of neuromuscular diseases, malignant tumors, or other severe uncontrolled conditions, including cardiac, renal, or hepatic diseases.
  2. Seated balance score < 2, or inability to maintain a sitting position for more than 60 minutes.
  3. Modified Ashworth Scale score > 2.
  4. Visual Analog Scale (VAS) score > 3 for hemiplegic shoulder pain.
  5. Boston Diagnostic Aphasia Examination score < 3.
  6. Severe visual impairment preventing participation in upper limb robot-assisted rehabilitation training.
  7. Hamilton Depression Scale score >17, indicating moderate to severe depressive symptoms.
  8. Participation in other clinical trials that may interfere with the results of this study.

Study details
    Stroke

NCT06876597

Lidian Chen

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.